secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2025-10-01T23:59:59+00:00
Accession:  0001628280-25-043491
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave Health appoints Coyle COO, removes Stegagno; terminates President Walko
--------------------------------------------------------------------------------

- Daniel Coyle appointed COO effective Sept 25, 2025; previously VP of Engineering.
- Former COO Peter Stegagno removed, appointed Chief Regulatory Officer; no longer an executive officer.
- President Andrew Walko terminated without cause effective Oct 24, 2025; no new President planned.
- Coyle's base salary set at $225,000, bonus at 40% of salary, and options for 60,000 shares vesting quarterly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025043491/0001628280-25-043491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025043491/snwv-20250925.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-043491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer